Locations:
Min Investment:
Max Investment:
Target Investment:
2015
2023
2015 - 2023
We are a clinical stage company dedicated to developing novel biologics that are both safe and efficacious for use in combination with anticancer antibodies to help the immune system eradicate cancer. More information at: http://alxoncology.com/
2015 - 2023
2015
2015
2007 - 2015
2009 - 2015
CSO (Chief Scientific Officer) of Rinat (acquired by Pfizer) and reporting to Dr. Mikael Dolsten, M.D. President of Pfizer World Research and Development (WRD). I also served as SVP at Pfizer and member of the Pfizer WRD Leadership Team, served as Chief Technology Officer for Pfizer Biotherapeutics, member of Pfizer Senior Leadership Council and Pfizer South San Francisco Site Head.
2008 - 2009
2007 - 2009
I am responsible for Rinat. Rinat is a scientifically independent company within a new Biotherapeutic initiative of Pfizer: The Biotherapeutics and Bioinnovation Centre (BBC). Reporting to Corey Goodman, companies in the BBC keep most of their independence while work closely with Pfizer to expand the biotherapeutics portfolio, the result is an organization that combines Biotech spirit with Pfizer’s Research, Development and Commercial capabilities.
1999 - 2002
1999 - 2002
1996 - 1999
1996 - 1999